|
Name |
Type |
Discontinued? |
|
| 1 |
RESULT_ID |
VARCHAR |
No |
|
|
|
| The unique identifier for the result record. |
|
|
| 2 |
TUMOR_SITE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify tumor site. |
|
|
| 3 |
CAP_COMMENTS |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: General comments. |
|
|
| 4 |
SPEC_PROC_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify the Specimen Procedure. |
|
|
| 5 |
TUMOR_OTHER_SIZE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Other Tumor Size. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Greatest dimension |
| Cannot be determined |
|
|
| 6 |
TUMOR_OTHER_GREAT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Other Tumor Size Greatest. |
|
|
| 7 |
TUMOR_OTHER_ADDT1 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Other Tumor Size Additional. |
|
|
| 8 |
TUMOR_OTHER_ADDT2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Other Tumor Size Additional 2. |
|
|
| 9 |
TUMOR_SIZE_GREAT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Greatest Size. |
|
|
| 10 |
TUMOR_SIZE_ADDL |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (length). |
|
|
| 11 |
TUMOR_SIZE_ADDL2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (width). |
|
|
| 12 |
TUMOR_SIZE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Tumor Size. |
|
|
| 13 |
HISTO_TYPE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify histologic type. |
|
|
| 14 |
EFFUSIONS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Effusions. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Positive ascites / peritoneal washings |
| Positive pleural effusions |
| Indeterminate |
|
|
| 15 |
SPECIMEN_OTHER_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify other specimen. |
|
|
| 16 |
ADDL_PATH_FIND_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify additional pathologic findings. |
|
|
| 17 |
CLINICAL_HIST_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify clinical history. |
|
|
| 18 |
HISTOLOGIC_GRADE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Grade. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| GX: Cannot be assessed |
| G1: Well differentiated |
| G2: Moderately differentiated |
| G3: Poorly differentiated |
| G4: Undifferentiated |
| G4: Undifferentiated / anaplastic |
| WHO grade not assigned |
| Low-grade (well-differentiated to moderately differentiated) |
| High-grade (poorly differentiated to undifferentiated) |
| FIGO Grade 1 |
| FIGO Grade 2 |
| FIGO Grade 3 |
| Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in |
| Less favorable (all subtypes other than those designated "Favorable" or "Unfavorable" |
| Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo |
| Gleason Pattern |
| Ungraded sarcoma |
| pGX: Grade cannot be assessed |
| pG1: Spindle cell melanoma |
| pG2: Mixed cell melanoma |
| pG3: Epithelioid cell melanoma |
| WHO Grade I |
| WHO Grade II |
| WHO Grade III |
| WHO Grade IV |
| pG1: Well differentiated |
| pG2: Moderately differentiated |
| pG3: Poorly differentiated |
| pG4: Undifferentiated |
| FNCLCC Grade 1 |
| FNCLCC Grade 2 |
| FNCLCC Grade 3 |
| Grade 1 |
| Grade 2 |
| Grade 3 |
| Cannot be determined |
| Other |
|
|
| 19 |
HISTOLGC_GRADE_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify histologic grade. |
|
|
| 20 |
LYMPH_ND_SAMPL_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify lymph node sampling. |
|
|
| 21 |
METASTASIS_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Metastasis Specify. |
|
|
| 22 |
TUMOR_OVARY_RIGHT_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Size Right Ovary. |
| May contain organization-specific values: Yes |
| Category Entries: |
| No tumor |
| Confined to surface epithelium |
| Surface and cortical stroma involvement |
| Only ovarian substance involvement |
| Greatest dimension |
| Cannot be determined |
|
|
| 23 |
TUMOR_OVARY_RI_GR |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size Right Ovary Greatest. |
|
|
| 24 |
TUMOR_OVARY_RI_GR2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size Right Ovary Greatest 2. |
|
|
| 25 |
TUMOR_OVARY_GR_ADD |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size Right Ovary Additional Dimension. |
|
|
| 26 |
TUMOR_OVARY_GR_SPEC |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Size Right Ovary Specify. |
|
|
| 27 |
TUMOR_OVARY_LEFT_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Size Left Ovary. |
| May contain organization-specific values: Yes |
| Category Entries: |
| No tumor |
| Confined to surface epithelium |
| Surface and cortical stroma involvement |
| Only ovarian substance involvement |
| Greatest dimension |
| Cannot be determined |
|
|
| 28 |
TUMOR_OVARY_LF_GR |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size Left Ovary Greatest. |
|
|
| 29 |
TUMOR_OVARY_LF_GR2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size Left Ovary Greatest 2. |
|
|
| 30 |
TUMOR_OVARY_LF_ADD |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size Left Ovary Additional Dimension. |
|
|
| 31 |
TUMOR_OVARY_LF_SPEC |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Size Left Ovary Specify. |
|
|
| 32 |
HIS_TYP_MAL_MESO_SP |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Type Malignant mesothelioma Specify. |
|
|
| 33 |
HIS_TYP_MAL_MULL_SP |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Type Other malignant tumor of Mullerian type specify. |
|
|
| 34 |
TUMOR_OTHER_SPEC1 |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Other Tumor Size Specify. |
|
|
| 35 |
TUMOR_OVARY_RI_SP2 |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Size Right Ovary Specify 2. |
|
|
| 36 |
TUMOR_OVARY_LF_SP2 |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Size Left Ovary Specify 2. |
|
|
| 37 |
TUMOR_OTHER_SPEC2 |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Other Tumor Size Specify 2. |
|
|
| 38 |
ANCLR_STD_SPEC |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify details for ancillary studies. |
|
|